Colossal Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Colossal Biosciences's estimated annual revenue is currently $37.8M per year.
- Colossal Biosciences's estimated revenue per employee is $193,750
- Colossal Biosciences's total funding is $225M.
- Colossal Biosciences's current valuation is $1.2B. (January 2023)
Employee Data
- Colossal Biosciences has 195 Employees.
- Colossal Biosciences grew their employee count by 27% last year.
Colossal Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Colossal Biosciences?
The science of genetics. The business of discovery. Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.
keywords:N/A
$225M
Total Funding
195
Number of Employees
$37.8M
Revenue (est)
27%
Employee Growth %
$1.2B
Valuation
N/A
Accelerator
Other Companies in Dallas
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $53.6M | 195 | 27% | N/A |
#2 | $53.8M | 195 | -3% | N/A |
#3 | $38.8M | 196 | 2% | N/A |
#4 | $32.7M | 198 | 8% | N/A |
#5 | $59.9M | 198 | 3% | N/A |